Literature DB >> 17180299

Juvenile onset systemic sclerosis: a single center experience of 23 cases from Asia.

Ramnath Misra1, Gurmeet Singh, Parshant Aggarwal, Amita Aggarwal.   

Abstract

The aim of this paper was to study the spectrum of juvenile scleroderma (JSSc) seen at a tertiary care referral center in Asia. Retrospective analysis of case records of patients with systemic sclerosis, having age of onset less than 16 years and seen at our hospital from 1988 to 2004, was done. Patients with linear scleroderma and morphea were excluded. There were 23 patients (19 girls, 4 boys) with median age of onset of 12 years (range 5-16 years). The median age at presentation was 17 years (range 10-34 years). The median time from first symptoms to presentation was 4 years (range 0.2-26 years). Among these, 14 had diffuse systemic sclerosis (DSSc), while 9 had limited scleroderma (LSSc). The clinical features seen at presentation in patients were: Raynaud's phenomenon in 19, digital ulcers in 14, loss of finger tip pulp in 12, reflux in 8, dysphagia in 7, arthritis in 8, digital gangrene in 2, and pulmonary artery hypertension in 1. Antinuclear antibody was positive in 15 out of 18 patients tested. Interstitial lung disease was seen in 15 patients, 6 of whom had diffuse disease. The median skin score was 22 (range 7-48) . One patient died of primary pulmonary hypertension within 1 year of onset of symptoms. At a mean follow-up of 34 months, 14 patients were stable or had improvement in skin score or dyspnea on exertion. DSSc and LSSc in childhood have a clinical presentation similar to adult patients, with cardiopulmonary involvement being the major predictor of outcome. The short-term prognosis of JSSc is good.

Entities:  

Mesh:

Year:  2006        PMID: 17180299     DOI: 10.1007/s10067-006-0483-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  17 in total

1.  Progressive systemic sclerosis in south India.

Authors:  V Krishnamurthy; R Porkodi; S Ramakrishnan; C P Rajendran; R Madhavan; K Achuthan; M Parthiban; A N Chandrasekaran
Journal:  J Assoc Physicians India       Date:  1991-03

2.  Raynaud syndrome in childhood.

Authors:  C M Duffy; R M Laxer; P Lee; C Ramsay; M Fritzler; E D Silverman
Journal:  J Pediatr       Date:  1989-01       Impact factor: 4.406

3.  Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey.

Authors:  I Foeldvari; M Zhavania; N Birdi; R J Cuttica; S H de Oliveira; P B Dent; R Elborgh; F Falcini; G Ganser; H Girschick; R Häfner; R Joos; W Kuis; P Pelkonen; A M Prieur; K Rostropowicz-Denisiewicz; R Russo; A Savolainen; A Siamopoulou-Mayridou; F Zulian
Journal:  Rheumatology (Oxford)       Date:  2000-05       Impact factor: 7.580

4.  Survival with first-line bosentan in patients with primary pulmonary hypertension.

Authors:  V V McLaughlin; O Sitbon; D B Badesch; R J Barst; C Black; N Galiè; M Rainisio; G Simonneau; L J Rubin
Journal:  Eur Respir J       Date:  2005-02       Impact factor: 16.671

Review 5.  Scleroderma in children.

Authors:  Francesco Zulian
Journal:  Pediatr Clin North Am       Date:  2005-04       Impact factor: 3.278

6.  Systemic sclerosis: using high-resolution CT to detect lung disease in children.

Authors:  J M Seely; L T Jones; C Wallace; D Sherry; E L Effmann
Journal:  AJR Am J Roentgenol       Date:  1998-03       Impact factor: 3.959

7.  [Scleroderma in children: a retrospective study of 70 cases].

Authors:  C Bodemer; M Belon; D Hamel-Teillac; J C Amoric; S Fraitag; A M Prieur; Y De Prost
Journal:  Ann Dermatol Venereol       Date:  1999-10       Impact factor: 0.777

8.  Long-term outcomes of scleroderma renal crisis.

Authors:  V D Steen; T A Medsger
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

9.  Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease.

Authors:  Kenneth Scalapino; Thaschawee Arkachaisri; Mary Lucas; Noreen Fertig; David J Helfrich; Aldo V Londino; Virginia D Steen; Thomas A Medsger
Journal:  J Rheumatol       Date:  2006-04-01       Impact factor: 4.666

10.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05
View more
  12 in total

Review 1.  A Practical Approach to Juvenile Dermatomyositis and Juvenile Scleroderma.

Authors:  Liza J McCann; Clare E Pain
Journal:  Indian J Pediatr       Date:  2016-02       Impact factor: 1.967

2.  Juvenile systemic sclerosis: experience from a tertiary care center from India.

Authors:  Narendra Kumar Bagri; Dinesh Raj; Jasmeet Kaur; Harish Punia; Isha Saini; Rakesh Lodha; S K Kabra
Journal:  Rheumatol Int       Date:  2017-08-22       Impact factor: 2.631

3.  Interstitial Lung Disease in Children Older Than 2 Years.

Authors:  Timothy J Vece; Leland L Fan
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

4.  Clinical and laboratory profile of juvenile-onset systemic sclerosis in a Brazilian cohort.

Authors:  Percival D Sampaio-Barros; Adriana B Bortoluzzo; Ana Paula T Del Rio; Ana Paula Luppino-Assad; Danieli Co Andrade; João Francisco Marques-Neto
Journal:  J Scleroderma Relat Disord       Date:  2018-04-24

5.  Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort.

Authors:  Ivan Foeldvari; Jens Klotsche; Kathryn S Torok; Ozgur Kasapcopur; Amra Adrovic; Valda Stanevicha; Maria Teresa Terreri; Ekaterina Alexeeva; Maria Katsicas; Rolando Cimaz; Mikhail Kostik; Thomas Lehman; Walter-Alberto Sifuentes-Giraldo; Vanessa Smith; Flavio Sztajnbok; Tadej Avcin; Maria Jose Santos; Monika Moll; Dana Nemcova; Cristina Battagliotti; Despina Eleftheriou; Mahesh Janarthanan; Tilmann Kallinich; Jordi Anton; Kirsten Minden; Susan Nielsen; Yosef Uziel; Nicola Helmus
Journal:  J Scleroderma Relat Disord       Date:  2018-08-07

Review 6.  Current developments in pediatric systemic sclerosis.

Authors:  Ivan Foeldvari
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

Review 7.  Rare Lung Diseases: Interstitial Lung Diseases and Lung Manifestations of Rheumatological Diseases.

Authors:  Mahesh Babu Ramamurthy; Daniel Y T Goh; Michael Teik Chung Lim
Journal:  Indian J Pediatr       Date:  2015-08-20       Impact factor: 1.967

8.  The frequency of pulmonary hypertension in patients with juvenile scleroderma.

Authors:  Amra Adrovic; Funda Oztunc; Kenan Barut; Aida Koka; Refet Gojak; Sezgin Sahin; Tuncalp Demir; Ozgur Kasapcopur
Journal:  Bosn J Basic Med Sci       Date:  2015-08-22       Impact factor: 3.363

Review 9.  [Scleroderma in childhood and adolescence. New aspects on classification, etiology and therapy].

Authors:  H J Girschick
Journal:  Z Rheumatol       Date:  2008-03       Impact factor: 1.372

10.  Juvenile Scleroderma: A Referral Center Experience.

Authors:  Amra Adrovic; Sezgin Şahin; Kenan Barut; Özgür Kasapçopur
Journal:  Arch Rheumatol       Date:  2018-01-18       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.